|
|
|
Volumn 27, Issue 3 SUPPL. 6, 2000, Pages 41-46
|
|
Future directions in the treatment of malignant gliomas with temozolomide
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CARMUSTINE;
CISPLATIN;
TEMOZOLOMIDE;
TOPOTECAN;
ARTICLE;
BONE MARROW TRANSPLANTATION;
CANCER CHEMOTHERAPY;
CANCER RADIOTHERAPY;
DRUG BIOAVAILABILITY;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG SAFETY;
GENE THERAPY;
GLIOBLASTOMA;
PRIORITY JOURNAL;
ANTINEOPLASTIC AGENTS, ALKYLATING;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BIOLOGICAL AVAILABILITY;
BONE MARROW TRANSPLANTATION;
BRAIN NEOPLASMS;
CARMUSTINE;
CISPLATIN;
COMBINED MODALITY THERAPY;
DACARBAZINE;
DRUG RESISTANCE, NEOPLASM;
GENE THERAPY;
GLIOBLASTOMA;
HUMANS;
TOPOTECAN;
|
|
EID: 0034120215
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (33)
|
|
References (36)
|
